Should Hospital Pharmacies That Are Not Fully Compliant with USP General Chapter <797> Standards Outsource, to the Fullest Extent Possible, the Preparation of Compounded Sterile Products to a Facility That Is Compliant?
出版信息
Can J Hosp Pharm. 2014 Nov;67(6):455-7. doi: 10.4212/cjhp.v67i6.1410.
Abstract
摘要
相似文献
1
Should Hospital Pharmacies That Are Not Fully Compliant with USP General Chapter <797> Standards Outsource, to the Fullest Extent Possible, the Preparation of Compounded Sterile Products to a Facility That Is Compliant?对于未完全符合美国药典通则<797>标准的医院药房，是否应尽可能将无菌制剂的配制工作外包给一家符合标准的机构？
Can J Hosp Pharm. 2014 Nov;67(6):455-7. doi: 10.4212/cjhp.v67i6.1410.
2
Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.加拿大医院药房无菌混合操作调查：第2部分。更多结果与讨论。
Can J Hosp Pharm. 2009 May;62(3):192-203.
3
Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.加拿大医院药房无菌混合操作调查：第1部分。方法与结果。
Can J Hosp Pharm. 2009 Mar;62(2):100-11.
4
Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1.
Int J Pharm Compd. 2007 May-Jun;11(3):230-6.
5
6
Achievement of USP Chapter 797 Compliance By A 35-Bed Rural Hospital: A Case Study.一家拥有35张床位的乡村医院实现美国药典第797章合规：案例研究
Int J Pharm Compd. 2007 Nov-Dec;11(6):450-70.
7
National survey of quality assurance activities for pharmacy-compounded sterile preparations.全国药房配制无菌制剂质量保证活动调查。
Am J Health Syst Pharm. 2003 Dec 15;60(24):2567-76. doi: 10.1093/ajhp/60.24.2567.
8
Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.无菌配制药房：要求和不要求遵守美国药典<797>与美国食品药品监督管理局483表格的州。
Ther Innov Regul Sci. 2016 May;50(3):279-303. doi: 10.1177/2168479016636417.
9
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.实施美国药典第797章——药物配制-无菌制剂，第5部分：配制制剂的准确性、无菌性和灭菌验证的注意事项。
Int J Pharm Compd. 2008 Jan-Feb;12(1):54-60.
10
Leveraging a multidisciplinary oversight committee to ensure USP <797> and <800> compliance at a Veterans Affairs health system.利用多学科监督委员会确保退伍军人事务部卫生系统符合 USP<797>和<800>。
Am J Health Syst Pharm. 2022 Feb 8;79(4):276-282. doi: 10.1093/ajhp/zxab412.
本文引用的文献
1
Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.2000-12 年与药剂配制机构相关的卫生保健相关性感染爆发的描述。
Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049.
2
Potential risks of pharmacy compounding.药剂配制的潜在风险。
Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9.
3
Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.加拿大医院药房无菌混合操作调查：第2部分。更多结果与讨论。
Can J Hosp Pharm. 2009 May;62(3):192-203.
4
Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.加拿大医院药房无菌混合操作调查：第1部分。方法与结果。
Can J Hosp Pharm. 2009 Mar;62(2):100-11.
5
Survey of sterile product compounding practices in Canadian hospital pharmacies.加拿大医院药房无菌产品配制实践调查。
Can J Hosp Pharm. 1993 Dec;46(6):249-60.
Zotero 插件